LENSAR, Inc. (LNSR): Price and Financial Metrics
GET POWR RATINGS... FREE!
LNSR Stock Price Chart Interactive Chart >
LNSR Price/Volume Stats
| Current price | $8.23 | 52-week high | $12.71 |
| Prev. close | $8.36 | 52-week low | $3.16 |
| Day low | $8.15 | Volume | 48,800 |
| Day high | $8.30 | Avg. volume | 36,087 |
| 50-day MA | $7.72 | Dividend yield | N/A |
| 200-day MA | $0.00 | Market Cap | 89.98M |
LENSAR, Inc. (LNSR) Company Bio
LENSAR, Inc. develops laser technologies. The Company provides autoprecision laser and proprietary 3-D imaging, measurement, and guidance system for refractive cataract surgery. LENSAR serves the healthcare industries throughout the United States.
Latest LNSR News From Around the Web
Below are the latest news stories about LENSAR Inc that investors may wish to consider to help them evaluate LNSR as an investment opportunity.
LENSAR Reports First Quarter 2021 Financial Results and Provides Business UpdateLENSAR, Inc. (Nasdaq: LNSR) ("LENSAR" or "the Company"), a global medical technology company focused on advanced femtosecond laser surgical solutions for the treatment of cataracts, today announced financial results for the first quarter ended March 31, 2021 and provided an update on key strategic and operational initiatives. |
LENSAR Inc to Host Earnings CallNEW YORK, NY / ACCESSWIRE / May 5, 2021 / LENSAR Inc (NASDAQ:LNSR) will be discussing their earnings results in their 2021 First Quarter Earnings call to be held on May 5, 2021 at 8:30 AM Eastern Time.To listen to the event live or access a replay of the call - visit https://www. |
LENSAR to Hold First Quarter 2021 Financial Results Conference Call on Wednesday, May 5, 2021LENSAR, Inc. (NASDAQ: LNSR) ("LENSAR" or "the Company"), a global medical technology company focused on advanced femtosecond laser surgical solutions for the treatment of cataracts, today announced that the Company’s first quarter 2021 financial results will be released before market open on Wednesday, May 5, 2021. LENSAR’s management will host a conference call and webcast at 8:30 am ET on Wednesday, May 5, 2021 to discuss the financial results and recent corporate highlights. |
LENSAR Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business UpdateLENSAR, Inc. (Nasdaq: LNSR) ("LENSAR" or "the Company"), a global medical technology company focused on advanced femtosecond laser surgical solutions for the treatment of cataracts, today announced financial results for the fourth quarter and full year ended December 31, 2020 and provided an update on key strategic and operational initiatives. |
LENSAR to Hold Fourth Quarter and Full Year 2020 Financial Results and Business Update Conference Call on Wednesday, March 10, 2021LENSAR, Inc. (NASDAQ: LNSR) ("LENSAR" or "the Company"), a global medical technology company focused on advanced femtosecond laser surgical solutions for the treatment of cataracts, today announced that the Company’s fourth quarter and full year 2020 financial results will be released before market open on Wednesday, March 10, 2021. LENSAR’s management will host a conference call and webcast at 8:30 am ET on Wednesday, March 10, 2021 to discuss the financial results and recent corporate highlights. |
LNSR Price Returns
| 1-mo | 4.31% |
| 3-mo | -0.84% |
| 6-mo | 13.05% |
| 1-year | N/A |
| 3-year | N/A |
| 5-year | N/A |
| YTD | 13.52% |
| 2020 | N/A |
| 2019 | N/A |
| 2018 | N/A |
| 2017 | N/A |
| 2016 | N/A |
Loading social stream, please wait...